Consolidated Statement of Changes in Shareholders' Deficit - USD ($)	Common Stock	Common Stock Issuable	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2016	$ 6,575	$ 6,451	$ 1,199,511	$ (2,124,219)	$ (911,682)
Balance, Shares at Dec. 31, 2016	65,753,640
Sale of common stock	$ 610		758,654		759,264
Sale of common stock, Shares	6,096,197
Fair value of warrants allocated to proceeds of common stock			89,376		89,376
Fair value of warrants allocated to proceeds of convertible notes payable			73,696		73,696
Fair value of warrants issued pursuant to Amended Investment Agreement			153,625		153,625
Fair value of warrants issued to extend convertible notes payable			290,581		290,581
Consultant fees payable with common shares and warrants	$ 28	1,817	52,083		53,928
Consultant fees payable with common shares and warrants, Shares	276,850
Shares and options issued pursuant to employee equity incentive plan	$ 17	8	20,785		20,810
Shares and options issued pursuant to employee equity incentive plan, Shares	176,250
Repurchase and retirement of treasury shares
Net loss				(2,581,011)	(2,581,011)
Balance at Dec. 31, 2017	$ 7,230	8,276	2,638,311	(4,705,230)	(2,051,413)
Balance, Shares at Dec. 31, 2017	72,302,937
Sale of common stock	$ 988		2,450,180		2,451,168
Sale of common stock, Shares	9,875,228
Sale of common stock initially allocated to derivative financial instruments			(1,774,298)		(1,774,298)
Fair value of warrants allocated to proceeds of common stock			181,788		181,788
Fair value of warrants issued to extend related party notes payable			337,466		337,466
Fair value of warrants issued to extend convertible notes payable			229,900		229,900
Fair value of warrants issued to retire convertible notes payable			143,014		143,014
Shares issued with convertible notes payable	$ 4		5,593		5,597
Shares issued with convertible notes payable, Shares	35,000
Fair value of warrants issued for professional services			296,447		296,447
Derivative liabilities transferred to additional paid-in capital			2,783,372		2,783,372
Conversion of convertible notes payable to common stock	$ 38		42,173		42,211
Conversion of convertible notes payable to common stock, shares	384,839
Derivative liabilities reclassified into additional paid in capital for convertible notes payable conversion into shares			63,549		63,549
Consultant fees payable with common shares and warrants	$ 28	17,869	31,660		49,557
Consultant fees payable with common shares and warrants, Shares	277,147
Shares and options issued pursuant to employee equity incentive plan	$ 40	(8)	102,598		102,630
Shares and options issued pursuant to employee equity incentive plan, Shares	403,750
Exercise of warrants	$ 200		(200)
Exercise of warrants, Shares	2,000,001
Repurchase and retirement of treasury shares	$ (10)			(4,990)	(5,000)
Repurchase and retirement of treasury shares, Shares	(100,000)
Net loss				(5,790,835)	(5,790,835)
Balance at Dec. 31, 2018	$ 8,518	$ 26,137	$ 7,531,553	$ (10,501,055)	$ (2,934,847)
Balance, Shares at Dec. 31, 2018	85,178,902